PDCD1 and cancer: CTLA4 pathways restrict T cell activity at the early stage of immune response, whereas PD1 signaling plays roles in the later stage of immune response, protecting surrounding tissues at sites of chronic inflammation from damage.2 Both immune checkpoints are utilized by cancer cells to evade immune surveillance.